CD163 and neoplasm: We recently reported that statin use is associated with a reduction in CD68+CD163+ pro-tumourigenic tumour-associated macrophage (TAM) proportions in tumour parenchymal and stromal areas of human lung adenocarcinomas (Al Dujaily et al., 2020).